Published online on February 17, 2004, 10.1073/pnas.0308689100
PNAS | February 24, 2004 | vol. 101 | no. 8 | 2428-2433
Previous Article |
Table of Contents
| Next Article
IMMUNOLOGY
Multiple sclerosis: Brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood
Christian Skulina
,
Stephan Schmidt
,
Klaus Dornmair
,
Holger Babbe ¶,
Axel Roers ||,
Klaus Rajewsky 
,
Hartmut Wekerle
,
Reinhard Hohlfeld
, and
Norbert Goebels

Institute for Clinical Neuroimmunology, Ludwig-Maximilians University, 81377 Munich, Germany;
Max Planck Institute for Neurobiology, 82152 Martinsried, Germany;
Department of Neurology, University of Bonn, 53127 Bonn, Germany; ¶Department of Genetics and 
CBR Institute for Biomedical Research, Harvard Medical School, Boston, MA 02115; and ||Department of Dermatology, University of Cologne, 50931 Cologne, Germany
Contributed by Klaus Rajewsky, December 29, 2003
We surveyed the T cell receptor repertoire in three separate compartments (brain, cerebrospinal fluid, and blood) of two multiple sclerosis patients who initially had diagnostic brain biopsies to clarify their unusual clinical presentation but were subsequently confirmed to have typical multiple sclerosis. One of the brain biopsy specimens had been previously investigated by microdissection and single-cell PCR to determine the clonal composition of brain-infiltrating T cells at the single-cell level. Using complementarity-determining region 3 spectratyping, we identified several identical, expanded CD8+ (but not CD4+) T cell clones in all three compartments. Some of the expanded CD8+ T cells also occurred in sorted CD38+ blood cells, suggesting that they were activated. Strikingly, some of the brain-infiltrating CD8+ T cell clones persisted for >5 years in the cerebrospinal fluid and/or blood and may thus contribute to the progression of the disease.
View this table:
[in this window]
[in a new window]
|
Table 2. TCR-BV sequences identified in brain tissue, CSF cells, and sorted peripheral blood cells (PBL) from Patient A by CDR3 spectratyping
|
|
View this table:
[in this window]
[in a new window]
|
Table 3. TCR-BV sequences identified in brain tissue, CSF cells, and sorted peripheral blood cells (PBL) from patient B by CDR3 spectratyping
|
|
Abbreviations: TCR, T cell receptor; BV, V
; BJ, J
; BC, C
; CSF, cerebrospinal fluid; CDR3, complementarity-determining region 3; MS, multiple sclerosis; PBMC, peripheral blood mononuclear cell.
Data deposition: Sequence data for TCR
-chains in Tables 2 and 3 have been deposited in the GenBank database (accession nos. AY534307AY534315).

To whom correspondence should be addressed: Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, CH-8091 Zurich, Switzerland. E-mail: norbert.goebels{at}usz.ch.

CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:

|
 |

|
 |
 
I. Pirko, T. K. Nolan, S. K. Holland, and A. J. Johnson
Multiple Sclerosis: Pathogenesis and MR Imaging Features of T1 Hypointensities in Murine Model
Radiology,
March 1, 2008;
246(3):
790 - 795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cabrelle, I. Dell'Aica, L. Melchiori, S. Carraro, E. Brunetta, R. Niero, E. Scquizzato, G. D'Intino, L. Calza, S. Garbisa, et al.
Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease
J. Leukoc. Biol.,
January 1, 2008;
83(1):
212 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Serafini, B. Rosicarelli, D. Franciotta, R. Magliozzi, R. Reynolds, P. Cinque, L. Andreoni, P. Trivedi, M. Salvetti, A. Faggioni, et al.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
J. Exp. Med.,
November 26, 2007;
204(12):
2899 - 2912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Odoardi, N. Kawakami, W. E. F. Klinkert, H. Wekerle, and A. Flugel
Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease
PNAS,
November 20, 2007;
104(47):
18625 - 18630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Junker, J. Ivanidze, J. Malotka, I. Eiglmeier, H. Lassmann, H. Wekerle, E. Meinl, R. Hohlfeld, and K. Dornmair
Multiple sclerosis: T-cell receptor expression in distinct brain regions
Brain,
November 1, 2007;
130(11):
2789 - 2799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dutta and B. D. Trapp
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Neurology,
May 29, 2007;
68(22_suppl_3):
S22 - S31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. G. Marcondes, T. H. Burdo, S. Sopper, S. Huitron-Resendiz, C. Lanigan, D. Watry, C. Flynn, M. Zandonatti, and H. S. Fox
Enrichment and Persistence of Virus-Specific CTL in the Brain of Simian Immunodeficiency Virus-Infected Monkeys Is Associated with a Unique Cytokine Environment
J. Immunol.,
May 1, 2007;
178(9):
5812 - 5819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. JI and J. GOVERMAN
Experimental Autoimmune Encephalomyelitis Mediated by CD8+ T Cells
Ann. N.Y. Acad. Sci.,
April 1, 2007;
1103(1):
157 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Somma, G. Ristori, L. Battistini, S. Cannoni, G. Borsellino, A. Diamantini, M. Salvetti, R. Sorrentino, and M. T. Fiorillo
Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis
J. Leukoc. Biol.,
March 1, 2007;
81(3):
696 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Seitz, C. K. Schneider, J. Malotka, X. Nong, A. G. Engel, H. Wekerle, R. Hohlfeld, and K. Dornmair
Reconstitution of paired T cell receptor {alpha}- and beta-chains from microdissected single cells of human inflammatory tissues
PNAS,
August 8, 2006;
103(32):
12057 - 12062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gold, C. Linington, and H. Lassmann
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
Brain,
August 1, 2006;
129(8):
1953 - 1971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Peng, H. Shao, Y. Ke, P. Zhang, J. Xiang, H. J. Kaplan, and D. Sun
In Vitro Activation of CD8 Interphotoreceptor Retinoid-Binding Protein-Specific T Cells Requires not only Antigenic Stimulation but also Exogenous Growth Factors.
J. Immunol.,
April 15, 2006;
176(8):
5006 - 5014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Fainardi, R Rizzo, L Melchiorri, M Castellazzi, E Paolino, M R Tola, E Granieri, and O R Baricordi
Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis
Multiple Sclerosis,
February 1, 2006;
12(1):
2 - 12.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Niland, K. Banki, W. E. Biddison, and A. Perl
CD8+ T Cell-Mediated HLA-A*0201-Restricted Cytotoxicity to Transaldolase Peptide 168-176 in Patients with Multiple Sclerosis
J. Immunol.,
December 15, 2005;
175(12):
8365 - 8378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wiendl, U. Feger, M. Mittelbronn, C. Jack, B. Schreiner, C. Stadelmann, J. Antel, W. Brueck, R. Meyermann, A. Bar-Or, et al.
Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity
Brain,
November 1, 2005;
128(11):
2689 - 2704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Frohman, M. Filippi, O. Stuve, S. G. Waxman, J. Corboy, J. T. Phillips, C. Lucchinetti, J. Wilken, N. Karandikar, B. Hemmer, et al.
Characterizing the Mechanisms of Progression in Multiple Sclerosis: Evidence and New Hypotheses for Future Directions
Arch Neurol,
September 1, 2005;
62(9):
1345 - 1356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Friese and L. Fugger
Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
Brain,
August 1, 2005;
128(8):
1747 - 1763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P.A. Rice, H.-P. Hartung, and P. A. Calabresi
Anti-{alpha}4 integrin therapy for multiple sclerosis: Mechanisms and rationale
Neurology,
April 26, 2005;
64(8):
1336 - 1342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hohlfeld and H. Wekerle
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines
PNAS,
October 5, 2004;
101(suppl_2):
14599 - 14606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hohlfeld
Immunologic factors in primary progressive multiple sclerosis
Multiple Sclerosis,
May 1, 2004;
10(3_suppl):
S16 - S22.
[Abstract]
[PDF]
|
 |
|